Abstract

Cardiac resynchronization therapy (CRT) was introduced to restore left ventricular synchrony in patients with heart failure. Currently, more than 30% of patients do not respond to this therapy. CRT has proven its effectiveness in reducing morbidity and mortality in well-selected patients. A better understanding of the pathophysiological mechanisms, implantation techniques, and technological advances in devices has improved the response to this therapy. We present a case of a super-responder.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call